The author summarizes trends in the development of new biotechnology agents, in consumer-driven health care, and in evidence-based medicine, along with economic factors that will affect the pharmaceutical industry.
You are here
P&T® Journal contents for April 2004
Strategic Innovation in Health Care Delivery: Capturing the Full Potential of Biotechnology in Health Care
Representatives from a consortium of more than 30 organizations assembled to discuss the impact of the Medicare Modernization Act, and the newly approved Drug Discount Cards, on older patients.
Dr. Valuck discusses the advantages and shortcomings of the SSRIs compared with earlier antidepressant medications, with special emphasis on the new agent escitalopram oxalate (Lexapro™).
Continuing Education Credit
Dr. Ebert reviews the complicated processes of comparing antimicrobial agents and choosing the most appropriate antibiotic in clinical practice.